Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2010

01.02.2010 | Breast Oncology

National Quality Measures for Breast Centers (NQMBC): A Robust Quality Tool

Breast Center Quality Measures

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Measuring and improving quality of care is of primary interest to patients, clinicians, and payers. The National Consortium of Breast Centers (NCBC) has created a unique program to assess and compare the quality of interdisciplinary breast care provided by breast centers across the country.

Methods

In 2005 the NCBC Quality Initiative Committee formulated their initial series of 37 measurements of breast center quality, eventually called the National Quality Measures for Breast Centers (NQMBC). Measures were derived from published literature as well as expert opinion. An interactive website was created to enter measurement data from individual breast centers and to provide customized comparison reports. Breast centers submit information using data they collect over a single month on consecutive patients. Centers can compare their results with centers of similar size and demographic or compare themselves to all centers who supplied answers for individual measures. New data may be submitted twice yearly. Serially submitted data allow centers to compare themselves over time. NQMBC random audits confirm accuracy of submitted data. Early results on several initial measures are reported here.

Results

Over 200 centers are currently submitting data to the NQMBC via the Internet without charge. These measures provide insight regarding timeliness of care provided by radiologists, surgeons, and pathologists. Results are expressed as the mean average, as well as 25th, 50th, and 75th percentiles for each metric. This sample of seven measures includes data from over 30,000 patients since 2005, representing a powerful database. In addition, comparison results are available every 6 months, recognizing that benchmarks may change over time.

Conclusions

A real-time web-based quality improvement program facilitates breast center input, providing immediate comparisons with other centers and results serially over time. Data may be used by centers to recognize high-quality care they provide or to identify areas for quality improvement. Initial results demonstrate the power and potential of web-based tools for data collection and analysis from hundreds of centers who care for thousands of patients.
Literatur
7.
Zurück zum Zitat Perkins C, Balma D, Garcia R; Members of the Consensus Group; Susan G. Komen for the Cure. Why current breast pathology practices must be evaluated. A Susan G. Komen for the Cure white paper: June 2006. Breast J. 2007;13:443–7. Perkins C, Balma D, Garcia R; Members of the Consensus Group; Susan G. Komen for the Cure. Why current breast pathology practices must be evaluated. A Susan G. Komen for the Cure white paper: June 2006. Breast J. 2007;13:443–7.
8.
Zurück zum Zitat Malin J, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the National Initiative for Cancer Care Quality: How Can We Improve the Quality of Cancer Care in the United States? J Clin Oncol. 2006;24:626–34.CrossRefPubMed Malin J, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the National Initiative for Cancer Care Quality: How Can We Improve the Quality of Cancer Care in the United States? J Clin Oncol. 2006;24:626–34.CrossRefPubMed
9.
Zurück zum Zitat Neumayer L, Hosokawa P, Itani K, El-Tamer M, Henderson WG, Khuri SF. Multivariable predictors of postoperative surgical site infection after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204:1178–87.CrossRefPubMed Neumayer L, Hosokawa P, Itani K, El-Tamer M, Henderson WG, Khuri SF. Multivariable predictors of postoperative surgical site infection after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204:1178–87.CrossRefPubMed
10.
Zurück zum Zitat Khuri SF, Henderson WG, Daley J, Jonasson O, Lones RS, Campbell DA Jr. et al. Successful implementation of the Department of Veterans Affairs” National Surgical Quality Improvement Program in the private sector: the Patient Safety in Surgery Study. Ann Surg. 2008;248:329–36.CrossRefPubMed Khuri SF, Henderson WG, Daley J, Jonasson O, Lones RS, Campbell DA Jr. et al. Successful implementation of the Department of Veterans Affairs” National Surgical Quality Improvement Program in the private sector: the Patient Safety in Surgery Study. Ann Surg. 2008;248:329–36.CrossRefPubMed
11.
Zurück zum Zitat Committee on Redesigning Health Insurance Performance Measures, Payment, and Performance Improvement Programs, Institute of Medicine of the National Academies, Executive Summary. Rewarding Provider Performance: Aligning Incentives in Medicare. The National Academies Press, Sept 2006. http://www.nap.edu/catalog/11723.html. Accessed February 20, 2009. Committee on Redesigning Health Insurance Performance Measures, Payment, and Performance Improvement Programs, Institute of Medicine of the National Academies, Executive Summary. Rewarding Provider Performance: Aligning Incentives in Medicare. The National Academies Press, Sept 2006. http://​www.​nap.​edu/​catalog/​11723.​html. Accessed February 20, 2009.
12.
Zurück zum Zitat Hoy E. Measuring patient experiences of care. Bull Am Coll Surg. 2008;93:13–16.PubMed Hoy E. Measuring patient experiences of care. Bull Am Coll Surg. 2008;93:13–16.PubMed
13.
Zurück zum Zitat Sharp BA, Meikle SF, James MD, Steiner C, Remus D. NHQR/NHDR measures for women of reproductive age. Med Care. 2005;43 suppl:164–71.CrossRef Sharp BA, Meikle SF, James MD, Steiner C, Remus D. NHQR/NHDR measures for women of reproductive age. Med Care. 2005;43 suppl:164–71.CrossRef
14.
Zurück zum Zitat Andersen MR, Bowen DJ, Morea J, Stein KD, Baker F. Involvement in decision-making and breast cancer survivor quality of life. Health Psychol. 2009;28:29–37.CrossRefPubMed Andersen MR, Bowen DJ, Morea J, Stein KD, Baker F. Involvement in decision-making and breast cancer survivor quality of life. Health Psychol. 2009;28:29–37.CrossRefPubMed
15.
Zurück zum Zitat Waljee JF, Hawley S, Alderman AK, Morrow M, Katz SJ. Patient satisfaction with treatment of breast cancer: does surgeon specialization matter? J Clin Oncol. 2007;25:3694–8.CrossRefPubMed Waljee JF, Hawley S, Alderman AK, Morrow M, Katz SJ. Patient satisfaction with treatment of breast cancer: does surgeon specialization matter? J Clin Oncol. 2007;25:3694–8.CrossRefPubMed
19.
Zurück zum Zitat Zarbo RJ, Gephardt GN, Howanitz PJ. Intralaboratory timeliness of surgical pathology reports. Results of two College of American Pathologists Q-Probes studies of biopsies and complex specimen. Arch Pathol Lab Med. 1996;120:234–44.PubMed Zarbo RJ, Gephardt GN, Howanitz PJ. Intralaboratory timeliness of surgical pathology reports. Results of two College of American Pathologists Q-Probes studies of biopsies and complex specimen. Arch Pathol Lab Med. 1996;120:234–44.PubMed
20.
Zurück zum Zitat Novis DA, Zarbo RJ, Saladino AJ. Interinstitutional comparison of surgical biopsy diagnosis turnaround time: a College of American Pathologists Q-Probes study of 5384 surgical biopsies in 157 small hospitals. Arch Pathol Lab Med. 1998;122:951–6.PubMed Novis DA, Zarbo RJ, Saladino AJ. Interinstitutional comparison of surgical biopsy diagnosis turnaround time: a College of American Pathologists Q-Probes study of 5384 surgical biopsies in 157 small hospitals. Arch Pathol Lab Med. 1998;122:951–6.PubMed
21.
Zurück zum Zitat Nakhleh RE, Jones B, Zarbo RJ. Mammographically directed breast biopsies: a College of American Pathologists Q-Probes study of clinical physician expectations and of specimen handling and reporting characteristics in 434 institutions. Arch Pathol Lab Med. 1997;121:11–8.PubMed Nakhleh RE, Jones B, Zarbo RJ. Mammographically directed breast biopsies: a College of American Pathologists Q-Probes study of clinical physician expectations and of specimen handling and reporting characteristics in 434 institutions. Arch Pathol Lab Med. 1997;121:11–8.PubMed
22.
Zurück zum Zitat Buyske J. For the protection of the public and the good of the specialty: Maintenance of certification. Arch Surg. 2009;144:101–3.CrossRefPubMed Buyske J. For the protection of the public and the good of the specialty: Maintenance of certification. Arch Surg. 2009;144:101–3.CrossRefPubMed
23.
Zurück zum Zitat Williams SC, Schmaltz SP, Morton DJ, Koss RG, Loeb JM. Quality of care in U.S. hospitals as reflected by standardized measures, 2002–2004. N Engl J Med. 2005;353:255–264.CrossRefPubMed Williams SC, Schmaltz SP, Morton DJ, Koss RG, Loeb JM. Quality of care in U.S. hospitals as reflected by standardized measures, 2002–2004. N Engl J Med. 2005;353:255–264.CrossRefPubMed
24.
Zurück zum Zitat Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin EM, Ma A, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007;356:486–96.CrossRefPubMed Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin EM, Ma A, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007;356:486–96.CrossRefPubMed
25.
Zurück zum Zitat Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003;15:523–30.CrossRef Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003;15:523–30.CrossRef
26.
Zurück zum Zitat Donaldson M, ed. Measuring the quality of health care: a statement by the National Roundtable on Health Care Quality. Washington, DC: National Academy; 1999. Donaldson M, ed. Measuring the quality of health care: a statement by the National Roundtable on Health Care Quality. Washington, DC: National Academy; 1999.
28.
Zurück zum Zitat Tisnado DM, Rose-Ash DE, Malin JL, Adams JL, Ganz PA, Kahn KL. Financial incentives for quality in breast cancer care. Am J Manag Care. 2008;14:457–66.PubMed Tisnado DM, Rose-Ash DE, Malin JL, Adams JL, Ganz PA, Kahn KL. Financial incentives for quality in breast cancer care. Am J Manag Care. 2008;14:457–66.PubMed
29.
Zurück zum Zitat Rosenthal MB, Frank RG, Li Z, Epstein AM. Early experience with pay-for-performance: from concept to practice. JAMA. 2005;294:1788–93.CrossRefPubMed Rosenthal MB, Frank RG, Li Z, Epstein AM. Early experience with pay-for-performance: from concept to practice. JAMA. 2005;294:1788–93.CrossRefPubMed
30.
Zurück zum Zitat Personal communication, Lillie Shockney RN, BS, MAS, May, 2005. Personal communication, Lillie Shockney RN, BS, MAS, May, 2005.
31.
Zurück zum Zitat Kothari A, Fentiman IS. Diagnostic delays in breast cancer and impact on survival. Int J Clin Pract. 2003;57:200–3.PubMed Kothari A, Fentiman IS. Diagnostic delays in breast cancer and impact on survival. Int J Clin Pract. 2003;57:200–3.PubMed
32.
Zurück zum Zitat Burack RC, Simon MS, Stano M, George J, Coombs J. Follow-up among women with an abnormal mammogram in an HMO: is it complete, timely, and efficient? Am J Manag Care. 2000;6:1102–13.PubMed Burack RC, Simon MS, Stano M, George J, Coombs J. Follow-up among women with an abnormal mammogram in an HMO: is it complete, timely, and efficient? Am J Manag Care. 2000;6:1102–13.PubMed
33.
Zurück zum Zitat Olivotto IA, Kan L, King S. Waiting for a diagnosis after an abnormal screening mammogram. SMPBC diagnostic process workgroup. Screening Mammography Program of British Columbia. Can J Public Health. 2000;91:113–7.PubMed Olivotto IA, Kan L, King S. Waiting for a diagnosis after an abnormal screening mammogram. SMPBC diagnostic process workgroup. Screening Mammography Program of British Columbia. Can J Public Health. 2000;91:113–7.PubMed
34.
Zurück zum Zitat Perez G, Porta M, Borrell C, Casamitjana M, et al. Interval from diagnosis to treatment onset for six major cancers in Catalonia, Spain. Cancer Detect Prev. 2008;32:267–75.CrossRefPubMed Perez G, Porta M, Borrell C, Casamitjana M, et al. Interval from diagnosis to treatment onset for six major cancers in Catalonia, Spain. Cancer Detect Prev. 2008;32:267–75.CrossRefPubMed
35.
Zurück zum Zitat Psooy BJ, Schreuer D, Borgaonkar J, Caines JS. Patient navigation: improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J. 2004;55:145–50.PubMed Psooy BJ, Schreuer D, Borgaonkar J, Caines JS. Patient navigation: improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J. 2004;55:145–50.PubMed
36.
Zurück zum Zitat Chang SW, Kerlikowske K, Napoles-Springer A, Posner SF, Sickles EA, Perez-Stable EJ. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer. 1996;78:1395–402.CrossRefPubMed Chang SW, Kerlikowske K, Napoles-Springer A, Posner SF, Sickles EA, Perez-Stable EJ. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer. 1996;78:1395–402.CrossRefPubMed
37.
Zurück zum Zitat Brucker SY, Schumacher C, Sohn C, et al. Benchmarking the quality of breast cancer care in a nationwide voluntary system: the first five-year results (2003-2007) from Germany as a proof of concept”. BMC Cancer. 2008;8:358. http://www.biomedcentral.com/1471-2407/8/358. Accessed February 12, 2009. Brucker SY, Schumacher C, Sohn C, et al. Benchmarking the quality of breast cancer care in a nationwide voluntary system: the first five-year results (2003-2007) from Germany as a proof of concept”. BMC Cancer. 2008;8:358. http://​www.​biomedcentral.​com/​1471-2407/​8/​358. Accessed February 12, 2009.
38.
Zurück zum Zitat Mano MP, Distante V, Tomatis M, Baiocchi D, et al. Audit system on quality of breast cancer diagnosis and treatment (QT): results of quality indicators on screen-detected lesions in Italy in 2005 and preliminary results for 2006. Epidemiol Prev. 2008;32:77–84. Mano MP, Distante V, Tomatis M, Baiocchi D, et al. Audit system on quality of breast cancer diagnosis and treatment (QT): results of quality indicators on screen-detected lesions in Italy in 2005 and preliminary results for 2006. Epidemiol Prev. 2008;32:77–84.
39.
Zurück zum Zitat Cheng SH, Wang CJ, Lin JL, Horng CF, Lu MC, et al. Adherence to quality indicators and survival in patients with breast cancer. Med Care. 2009;47:217–25.CrossRefPubMed Cheng SH, Wang CJ, Lin JL, Horng CF, Lu MC, et al. Adherence to quality indicators and survival in patients with breast cancer. Med Care. 2009;47:217–25.CrossRefPubMed
40.
Zurück zum Zitat Chen CY, Tzeng WS, Tsai CC, Mak CW, Chen CH, Chou MC. Adjusting mammography-audit recommendations in a lower-incidence Taiwanese population. J Am Coll Radol. 2008;5:978–85. Chen CY, Tzeng WS, Tsai CC, Mak CW, Chen CH, Chou MC. Adjusting mammography-audit recommendations in a lower-incidence Taiwanese population. J Am Coll Radol. 2008;5:978–85.
41.
Zurück zum Zitat Feig SA. Auditing and benchmarks in screening and diagnostic mammography. Radiol Clin North Am. 2007;45:791–800.CrossRefPubMed Feig SA. Auditing and benchmarks in screening and diagnostic mammography. Radiol Clin North Am. 2007;45:791–800.CrossRefPubMed
42.
Zurück zum Zitat Razavi AR, Gill H, Ahlfeldt H, Shahsavar N. Non-compliance with a postmastectomy radiotherapy guideline: Decision tree and cause analysis. BMC Med Informatics Decision Making. 2008;8:41–9. Razavi AR, Gill H, Ahlfeldt H, Shahsavar N. Non-compliance with a postmastectomy radiotherapy guideline: Decision tree and cause analysis. BMC Med Informatics Decision Making. 2008;8:41–9.
43.
Zurück zum Zitat Olivotto IA, Bancej C, Goel V, Snider J, McAuley RG, Irvine B, et al. Waiting times form abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ. 2001;165:277–83.PubMed Olivotto IA, Bancej C, Goel V, Snider J, McAuley RG, Irvine B, et al. Waiting times form abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ. 2001;165:277–83.PubMed
44.
Zurück zum Zitat Kaufman CS, Delbecq R, Jacobson L. Excising the re-excision: stereotactic core biopsy decreases need for re-excision of breast cancer. World J Surg. 1998;22:1023–8.CrossRefPubMed Kaufman CS, Delbecq R, Jacobson L. Excising the re-excision: stereotactic core biopsy decreases need for re-excision of breast cancer. World J Surg. 1998;22:1023–8.CrossRefPubMed
45.
Zurück zum Zitat Pocock B, Taback B, Klein L, Joseph KA, El-Tamer M. Preoperative needle biopsy as a potential quality measure in breast cancer surgery. Ann Surg Oncol. 2009;16:1108–11.CrossRefPubMed Pocock B, Taback B, Klein L, Joseph KA, El-Tamer M. Preoperative needle biopsy as a potential quality measure in breast cancer surgery. Ann Surg Oncol. 2009;16:1108–11.CrossRefPubMed
46.
Zurück zum Zitat Clarke-Pearson EM, Jacobson AF, Boolbol SK, Leitman IM, Friedmann P, Lavarias V, et al. Quality assurance initiative at one institution for minimally invasive breast biopsy as the initial diagnostic technique. J Am Coll Surg. 2009;208:75–8.CrossRefPubMed Clarke-Pearson EM, Jacobson AF, Boolbol SK, Leitman IM, Friedmann P, Lavarias V, et al. Quality assurance initiative at one institution for minimally invasive breast biopsy as the initial diagnostic technique. J Am Coll Surg. 2009;208:75–8.CrossRefPubMed
47.
Zurück zum Zitat Silverstein MJ, Lagios MD, Recht A, Allred DC, Harms SE, Holland R, et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2005;201:586–97.CrossRefPubMed Silverstein MJ, Lagios MD, Recht A, Allred DC, Harms SE, Holland R, et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2005;201:586–97.CrossRefPubMed
48.
Zurück zum Zitat Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data. Cancer. 2009;115:716–24.CrossRefPubMed Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data. Cancer. 2009;115:716–24.CrossRefPubMed
49.
Zurück zum Zitat Holloway CM, Saskin R, Paszat L. Geographic variation and physician specialization in the use of percutaneous biopsy for breast cancer diagnosis. Can J Surg. 2008;51:453–63.PubMed Holloway CM, Saskin R, Paszat L. Geographic variation and physician specialization in the use of percutaneous biopsy for breast cancer diagnosis. Can J Surg. 2008;51:453–63.PubMed
50.
Zurück zum Zitat Lannin DR, Ponn T, ANdrejeva L, Philpotts L. Should all breast cancers be diagnosed by needle biopsy? Am J Surg. 2006;192:450–4.CrossRefPubMed Lannin DR, Ponn T, ANdrejeva L, Philpotts L. Should all breast cancers be diagnosed by needle biopsy? Am J Surg. 2006;192:450–4.CrossRefPubMed
51.
Zurück zum Zitat Kaufman CS. National quality validation programs for breast centers. Expert Rev Anticancer Therapy. 2007;7:1357–62.CrossRef Kaufman CS. National quality validation programs for breast centers. Expert Rev Anticancer Therapy. 2007;7:1357–62.CrossRef
53.
Zurück zum Zitat Kaufman CS. Validating quality breast care: three new validation programs for 2007. Am J Surg. 2007;194:515–7.CrossRefPubMed Kaufman CS. Validating quality breast care: three new validation programs for 2007. Am J Surg. 2007;194:515–7.CrossRefPubMed
58.
Zurück zum Zitat Winchester DP. The national accreditation program for breast centers: a multidisciplinary approach to improve the quality of care for patients with diseases of the breast. Breast J. 2008;14:409–11.CrossRefPubMed Winchester DP. The national accreditation program for breast centers: a multidisciplinary approach to improve the quality of care for patients with diseases of the breast. Breast J. 2008;14:409–11.CrossRefPubMed
Metadaten
Titel
National Quality Measures for Breast Centers (NQMBC): A Robust Quality Tool
Breast Center Quality Measures
Publikationsdatum
01.02.2010
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2010
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0729-5

Weitere Artikel der Ausgabe 2/2010

Annals of Surgical Oncology 2/2010 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.